Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma
Clinical trial NCT01121757 · TERMINATED
Trial details
- NCT number
- NCT01121757
- Sponsor
- Duke University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2013-03-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.